Application of Huperzine A in preparing medicaments

A technology of huperzine A and medicine, which is applied in the application field of huperzine A in pharmaceuticals, and achieves the effects of strong pharmacological effect, lowering eye pressure effect and good effect
CN101797252AInactive Publication Date: 2010-08-11SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
2 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
Publication Date
2010-08-11
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to application of Huperzine A in preparing medicaments, namely the application of the Huperzine A in preparing medicaments for preventing and treating glaucoma, increase of intraocular pressure and eye problems concomitant with retinal ganglion cell injury. The invention has the advantages that: 1, the new medical treatment application of the Huperzine A is developed, and a new application field is exploited; 2, the Huperzine A is safe and non-toxic, and has strong pharmacological effects, and good medicinal prospect of the Huperzine A is predicted; and 3, a great deal of cell and animal experimental study proves that the medicament Huperzine A has good effects of protecting retinal ganglion cell and reducing the intraocular pressure by oral administration and local eye dropping, and can be used for preventing and treating the glaucoma, the increase of intraocular pressure and the eye problems concomitant with retinal ganglion cell injury.
Need to check novelty before this filing date? Find Prior Art

Description

【Technical field】

[0001] The invention relates to a new application of huperzine A, in particular to an application in the field of pharmacy. 【Background technique】

[0002] Glaucoma is one of the most common clinical eye diseases, mainly manifested as increased intraocular pressure leading to fundus optic nerve head collapse, narrowed field of vision, decreased vision, severe cases may be blind, and once blind, will permanently lose vision. Its incidence rate accounts for about 1% of the whole population, and the incidence rate of people over 40 years old accounts for about 2.5%, which is extremely harmful.

[0003] Treatment of glaucoma has long been limited to the treatment of its main risk factor - ocular hypertension. After the intraocular pressure is controlled by drugs and / or surgery, the visual function impairment of most patients has been effectively curbed, but there are still a considerable number of patients, especially those with advanced glaucoma, whose visual...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More